Live from the NIH registry
Studies recruiting near Denver right now
Top 25 of 1,598 recruiting studies, sorted by proximity — each links to its official registry page
Mode of Exercise and Bone Biomarkers in Older Veterans
Aging, Musculoskeletal Diseases
N/A
Interventional 120 participants sought
Rocky Mountain Regional VA Medical Center, Aurora, CO — Aurora, Colorado (3.2 mi)
· Sponsor: VA Office of Research and Development
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Children's Hospital Colorado — Aurora, Colorado (3.2 mi)
· Sponsor: National Cancer Institute (NCI)
ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR)
Locally Advanced Solid Tumor, Metastatic Solid Tumor
Phase 1
Interventional 30 participants sought
SCRI Denver Drug Development Unit — Denver, Colorado (6.0 mi)
· Sponsor: Acepodia Biotech, Inc.
Type 1 Diabetes REst for Metabolic Health
Type 1 Diabetes (T1D), Sleep Health
N/A
Interventional 50 participants sought
Children's Hospital Colorado — Aurora, Colorado (3.2 mi)
· Sponsor: University of Colorado, Denver
Analysis of Prognostic Cell Signaling Factors in Adolescent Idiopathic Scoliosis
Adolescent Idiopathic Scoliosis
N/A
Observational 380 participants sought
Children'S Hospital of Colorado — Denver, Colorado (6.0 mi)
· Sponsor: University of Colorado, Denver
International Weight Control Registry
Weight Loss, Overweight
N/A
Observational 100,000 participants sought
University of Colorado, Denver — Denver, Colorado (6.0 mi)
· Sponsor: Tufts University
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Cystic Fibrosis (CF), Cystic Fibrosis-related Diabetes
N/A
Observational 200 participants sought
University of Colorado Denver — Aurora, Colorado (3.2 mi)
· Sponsor: Jaeb Center for Health Research
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
Barbara Davis Center for Childhood Diabetes — Aurora, Colorado (3.2 mi)
· Sponsor: Medtronic MiniMed, Inc.
BeSMART Secure Storage Counseling in the Inpatient Setting
Firearm Injury, Safety Issues
N/A
Interventional 400 participants sought
Children's Hospital Colorado — Aurora, Colorado (3.2 mi)
· Sponsor: Vanderbilt University Medical Center
Cannabidiol and Cannabis Concentrate Users
Cannabis Use Disorder
Phase 2
Interventional 120 participants sought
University of Colorado Anschutz Medical Campus — Aurora, Colorado (3.2 mi)
· Sponsor: University of Colorado, Denver
ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
Diffuse Intrinsic Pontine Gliomas (DIPG), Progressive DIPG
Phase 2
Interventional 60 participants sought
Children's Hospital Colorado — Aurora, Colorado (3.2 mi)
· Sponsor: Nationwide Children's Hospital
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
MTAP-deleted Solid Tumors
Phase 1, Phase 2
Interventional 450 participants sought
UCHealth Cancer Center - Anschutz Medical Campus - University of Colorado Cancer Center — Aurora, Colorado (3.2 mi)
· Sponsor: Bayer
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Rocky Mountain Cancer Centers-Aurora — Aurora, Colorado (3.2 mi)
· Sponsor: SWOG Cancer Research Network
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Bladder Carcinoma, Ureter Carcinoma
N/A
Observational 2,020 participants sought
University of Colorado — Aurora, Colorado (3.2 mi)
· Sponsor: Guardant Health, Inc.
REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors
Ovarian Cancer, Advanced Ovarian Carcinoma
N/A
Interventional 240 participants sought
University of Colorado Cancer Center-Anschutz — Aurora, Colorado (3.2 mi)
· Sponsor: Dana-Farber Cancer Institute
A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
Hyperphosphatemia, Chronic Kidney Disease Requiring Chronic Dialysis
Phase 2
Interventional 168 participants sought
Colorado Kidney Care — Denver, Colorado (6.0 mi)
· Sponsor: R1 Therapeutics
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Solid Tumor Cancer, Locally Advanced
Phase 1, Phase 2
Interventional 480 participants sought
Avenzo Therapeutics Recruiting Site — Denver, Colorado (6.0 mi)
· Sponsor: Avenzo Therapeutics, Inc.
Feasibility of the Reality PAWS Program for Children in Isolation
Inpatient Pediatric Care, Isolation
N/A
Interventional 50 participants sought
Children's Hospital Colorado Anschutz Medical Campus — Aurora, Colorado (3.2 mi)
· Sponsor: Children's Hospital Colorado
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Carcinoma, Transitional Cell, Urinary Bladder Neoplasms
Phase 3
Interventional 450 participants sought
AdventHealth Medical Group - Porter — Denver, Colorado (6.0 mi)
· Sponsor: Eli Lilly and Company
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
Narcolepsy Type 1
Phase 3
Interventional 150 participants sought
Alkermes Investigational Site — Boulder, Colorado (27.3 mi)
· Sponsor: Alkermes, Inc.
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL)
Phase 1
Interventional 248 participants sought
Sarah Cannon Research Institute at Colorado Blood Cancer Institute — Denver, Colorado (6.0 mi)
· Sponsor: Nurix Therapeutics, Inc.
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
Heart Failure
Phase 3
Interventional 1,500 participants sought
CON-10001, Aurora, CO — Aurora, Colorado (3.2 mi)
· Sponsor: Colorado Prevention Center
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
UCHealth University of Colorado Hospital — Aurora, Colorado (3.2 mi)
· Sponsor: NRG Oncology
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
ClinRe 001-001 — Thornton, Colorado (8.9 mi)
· Sponsor: Duke University
Creative Arts Program to Reduce Burnout in Healthcare Professionals
Burn-Out Syndrome, Post-Traumatic Stress Disorder
N/A
Interventional 195 participants sought
University of Colorado - Anschutz Medical Campus — Aurora, Colorado (3.2 mi)
· Sponsor: University of Colorado, Denver